Showing results (241-250 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|August 8, 2006
The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivityTetsuya Oguri, Hiroyuki Achiwa, Shigeki Sato, et al.
Molecular Cancer Therapeutics|August 8, 2006
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing miceLawrence D Mayer, Troy O Harasym, Paul G Tardi, et al.
Molecular Cancer Therapeutics|August 8, 2006
Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathwayHongbo Hu, Cheng Jiang, Todd Schuster, et al.
Molecular Cancer Therapeutics|August 8, 2006
Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspirationManuel Hidalgo, Maria Luz Amador, Antonio Jimeno, et al.
Molecular Cancer Therapeutics|March 1, 2006
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatmentBenjamin J Friedmann, Martyn Caplin, Boris Savic, et al.
Molecular Cancer Therapeutics|March 1, 2006
Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and functionCecile Rouleau, Andre Roy, Thia St Martin, et al.
Molecular Cancer Therapeutics|March 1, 2006
14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinomaHuiling Yang, Ruiying Zhao, Mong-Hong Lee
Molecular Cancer Therapeutics|March 1, 2006
Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connectionYu-Chin Lien, Shu-Mei Lin, Ramaneeya Nithipongvanitch, et al.
Molecular Cancer Therapeutics|March 1, 2006
An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: in vitro evaluationZhen-Guo Wang, Wenli Zhao, Murali Ramachandra, et al.
Molecular Cancer Therapeutics|March 1, 2006
c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cellsJaideep V Thottassery, Louise Westbrook, Hitoshi Someya, et al.
Pageof 601